undamentalytics Newsletter
Sign in

Senti Biosciences Holdings, Inc. revenue

Senti Biosciences Holdings, Inc.'s revenue was $22,000 in fiscal 2025. Since fiscal 2021 ($2.8m) it has grown at a compound -70.1% a year.

Revenue history

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025
Revenue2,7614,2862,561022
Growth on the year before—+55.2%−40.2%−100.0%—

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Senti Biosciences Holdings, Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Senti Biosciences Holdings, Inc.